POSTER: MM-309 CARTITUDE-1 Final Results: Phase 1b/2 Study of Ciltacabtagene Autoleucel in Heavily Pretreated Patients With Relapsed/Refractory Multiple MyelomaYi Lin, Sundar Jagannath, Andrzej Jakubowiak et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 2
Biomarker Correlates of 3 Year Response in Cartitude-1: A Phase 1b/2 Open-Label Study of Ciltacabtagene Autoleucel in Patients with Relapsed or Refractory Multiple MyelomaYi Lin, Rui Wang, Saad Z. Usmani et al.|Transplantation and Cellular Therapy|2024Cited by 1